Best Weight Loss Injections & Pills in Canada

No. Unlike the United States, Health Canada does not permit compounded versions of GLP-1 medications such as compounded semaglutide or tirzepatide for weight loss. Canadian providers only offer Health Canada-approved medications: brand-name options like Ozempic, Wegovy, Mounjaro, and Saxenda, plus approved generic semaglutide.

Health Canada has approved several GLP-1 medications including Mounjaro (tirzepatide), Wegovy (semaglutide 2.4 mg), Ozempic (semaglutide), Saxenda (liraglutide), and generic semaglutide (approved in 2025). All are available through licensed Canadian telehealth providers after a physician consultation.

Yes. Health Canada approved generic semaglutide from two manufacturers in 2025, making Canada one of the first countries with a lower-cost alternative to brand-name Ozempic. It contains the same active ingredient, follows the same weekly injection routine, and is available through online clinics from around $149 per month including the prescription and delivery.

Canadian telehealth weight loss clinics allow you to complete an intake online, receive a review from a licensed Canadian physician, and, if eligible, get a prescription for a Health Canada-approved GLP-1 medication shipped directly to you. No in-person clinic visit is required.

Generally, adults with a BMI of 30 or higher, or a BMI of 27 or higher with a weight-related health condition (such as type 2 diabetes or hypertension) may qualify. Each provider conducts their own clinical screening and a licensed physician makes the final determination.

Coverage varies by province and private plan. Some provincial drug benefit programs may cover certain GLP-1 medications for eligible conditions. Most Canadian telehealth weight loss providers offer transparent cash-pay pricing that includes the consultation and prescription.